Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age

NCT03143101 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Healthy

Interventions

BIOLOGICAL: FluMist trivalent (2015-2016)
BIOLOGICAL: FluMist Quadrivalent (2015-2016)
BIOLOGICAL: FluMist Quadrivalent (2017-2018)

Sponsor

MedImmune LLC

Collaborators

[object Object]